Tania De Jong from Mind Medicine Australia joins Mason for another inspiring and informative conversation on the topic of psychedelic assisted therapies.

In the time since Tania was last on the show, the TGA, Australia's Therapeutic Goods Administration, made the monumental decision to reduce the scheduling of MDMA and psilocybin, two key allies in the successful treatment of drug resistant mental health conditions. The ruling to reschedule these compounds from Schedule 9 Prohibited Substances to Schedule 8 Controlled Drugs is incredibly important for the future of psychedelic assisted therapies, and although their immediate legal application is only indicated for a narrow index of specialised cases; MDMA for drug resistant PTSD and psilocybin for drug resistant depression, it's a huge win for Australia as the front runners in the legalisation of this movement. Tania relays what these scheduling changes mean for the future of psychedelic assisted therapies, and introduces us to The Healthy Person’s Trial, an exciting new research experiment for therapists operating out of The Australian National University in Canberra. Tania shares her personal story with psychedelic assisted therapies, and the experiential journey that lead to the creation of Mind Medicine, the not for profit company she founded with her husband and business partner Peter. Tania speaks with grace and humility, eloquently educating on what's happening on the ground with this movement. A penetrating and illuminating listen for all.